Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer. - Wikidata - awgldk - TriplyDB

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

http://www.wikidata.org/entity/Q40449162

about

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study.Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer Capecitabine in gastric cancer.Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis.Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.Current approaches to gastric cancer in Korea.Capecitabine in the treatment of advanced gastric cancer.Upper gastrointestinal tumors: current status and future perspectives.Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer.The roles of surgical oncologists in the new era: minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer.Capecitabine for the treatment of gastric cancer.Global chemotherapy development for gastric cancer.Advanced gastric cancer: a disease of diverse clinical biology.Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI).Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.

P2860

Q33387432-7EE3F68A-106E-454D-B9FD-1165FD77852E Q33399530-4AC27ECC-02A4-4922-9B1C-0C476A3024A1 Q33413350-5927A731-7DB4-40FB-840F-6434E62DC242 Q33426501-AC0BA8A4-1147-4745-8F46-F51263DF1CFC Q33430940-F1794031-8A86-4265-9BAA-07C55F04ACD8 Q34236005-ADAEA212-4C95-410F-896E-36881BA8E105 Q34254234-07961339-6A80-4CB1-9A00-E4771811BA68 Q34658209-53FEC42C-6CBB-4308-BB69-609588D1B636 Q35068015-EDCB6153-17A6-492F-AA94-9FA786DA8458 Q35948050-B4472EBA-BA3F-4EFC-BC78-DB232710399E Q36402491-DAE8F9DC-1DAF-4BDA-B47F-A66812407DAF Q36477277-4B127628-950C-45C5-9B62-45869EED2758 Q36478140-E1C423A1-A3B5-4F76-A3A3-CB2EB9CB7E53 Q37077836-F52A8B57-CAEC-4CED-8E46-56E560F4DB69 Q37136996-9DEFF5E6-6777-42E5-A87B-08E0806FEDAC Q37183479-9FB57BB3-1D74-4067-A256-E68CA747D2E1 Q37477979-12A573F9-461A-40D1-8543-6E77F90DCC35 Q37959113-C6BB014A-4423-4516-B933-AF350D1490E5 Q38608072-80CB8258-343B-445E-9EC9-99C69CDBB46B Q38813532-824E1A32-FC88-41DB-BF60-D8BB466BF463 Q41830462-5B2EA3B9-5A96-4412-891B-83665FCE9EA1 Q51215133-82FE0F84-84DE-4F6B-A54D-BDA31D07A0B5 Q55005321-CC6BE675-A4D0-4588-8F8A-ED8063196A16 Q55514438-958E4004-5D3D-467A-9CC3-FD575D462054

P2860

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

http://www.wikidata.org/entity/Q40449162

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Capecitabine in combination wi ...... y for advanced gastric cancer.

@en

type

label

Capecitabine in combination wi ...... y for advanced gastric cancer.

@en

prefLabel

Capecitabine in combination wi ...... y for advanced gastric cancer.

@en

P1433

Q40449162-9802EB1C-60AA-4A90-A3EF-1DE738C38860

P1476

Q40449162-7D2F8BC6-142E-4D1F-894F-3F5840EDE4D4

P2093

Q40449162-066F1FA9-26BD-4258-8B9D-177D235D80A7

Q40449162-6C1FC814-9BC3-4740-99E8-61CF687E669E

Q40449162-71065B66-712C-4D32-BB09-E0659F4BA891

Q40449162-72A86A43-1291-4F00-B743-5F739E49547E

Q40449162-7F71A068-E546-49E1-AE94-AED61FD53ED5

Q40449162-A3AA0266-EE91-4E85-874C-7730CAA0B44C

Q40449162-A6C8F198-C774-41C4-9716-561556F6C04A

Q40449162-AC65B9E6-6BBB-408A-8B47-D2E32A1BC29E

Q40449162-C7DD5113-7D36-4728-B906-97C753B481B4

Q40449162-CCE20546-2500-465A-8BDC-803421701833

P2888

Q40449162-99309A0F-7F05-4B18-9124-C499AB14FCD3

P304

Q40449162-D2F88AB3-AEF2-4F53-9B28-27C51E9C99BA

P31

Q40449162-7736CD5B-B9DE-48EF-AA53-A69A4604C0EE

P356

Q40449162-AF514D40-2466-4D53-AB8B-2CCD416BA54F

P433

Q40449162-0C7EDDD3-694C-4C6D-999D-025E864BFA80

P478

Q40449162-EEEA06CD-A37C-4CC9-A359-BAC8CB72B620

P577

Q40449162-5B7D217F-0FAA-4ABB-93A0-54B095E6DB25

P6179

Q40449162-2905EAF7-C694-45B8-A4A2-BD625C31F37E

P698

Q40449162-B6A14651-E3C3-4323-816C-5F2FB40020C3

P356

S00280-007-0515-7

P1433

Cancer Chemotherapy and Pharmacology

P1476

Capecitabine in combination wi ...... y for advanced gastric cancer.

@en

P2093

Baek-Yeol Ryoo

http://www.w3.org/2001/XMLSchema#string

Bong Seog Kim

http://www.w3.org/2001/XMLSchema#string

Dong Bok Shin

http://www.w3.org/2001/XMLSchema#string

Heung Moon Chang

http://www.w3.org/2001/XMLSchema#string

Jae-Lyun Lee

http://www.w3.org/2001/XMLSchema#string

Min-Hee Ryu

http://www.w3.org/2001/XMLSchema#string

Sung Hyun Yang

http://www.w3.org/2001/XMLSchema#string

Tae Won Kim

http://www.w3.org/2001/XMLSchema#string

Yeon Hee Park

http://www.w3.org/2001/XMLSchema#string

Yoon-Koo Kang

http://www.w3.org/2001/XMLSchema#string

P2888

s00280-007-0515-7

P304

623-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-007-0515-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012055505

http://www.w3.org/2001/XMLSchema#string

P698

17522863

http://www.w3.org/2001/XMLSchema#string